These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12213183)

  • 1. Funding source, trial outcome and reporting quality: are they related? Results of a pilot study.
    Clifford TJ; Barrowman NJ; Moher D
    BMC Health Serv Res; 2002 Sep; 2(1):18. PubMed ID: 12213183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?
    Als-Nielsen B; Chen W; Gluud C; Kjaergard LL
    JAMA; 2003 Aug; 290(7):921-8. PubMed ID: 12928469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disclosure of funding sources and conflicts of interest in phase III surgical trials: survey of ten general surgery journals.
    Bridoux V; Moutel G; Schwarz L; Michot F; Herve C; Tuech JJ
    World J Surg; 2014 Oct; 38(10):2487-93. PubMed ID: 24824646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of journal impact factor, reporting conflicts, and reporting funding sources, on standardized effect sizes in back pain trials: a systematic review and meta-regression.
    Froud R; Bjørkli T; Bright P; Rajendran D; Buchbinder R; Underwood M; Evans D; Eldridge S
    BMC Musculoskelet Disord; 2015 Nov; 16():370. PubMed ID: 26620449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study.
    Montedori A; Bonacini MI; Casazza G; Luchetta ML; Duca P; Cozzolino F; Abraha I
    Trials; 2011 Feb; 12():58. PubMed ID: 21356072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between funding by commercial interests and study outcome in randomized controlled drug trials.
    Yaphe J; Edman R; Knishkowy B; Herman J
    Fam Pract; 2001 Dec; 18(6):565-8. PubMed ID: 11739337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of funding source, clinical trial outcome, and quality of reporting in orthopedic surgery literature.
    Khan SN; Mermer MJ; Myers E; Sandhu HS
    Am J Orthop (Belle Mead NJ); 2008 Dec; 37(12):E205-12; discussion E212. PubMed ID: 19212579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome reporting among drug trials registered in ClinicalTrials.gov.
    Bourgeois FT; Murthy S; Mandl KD
    Ann Intern Med; 2010 Aug; 153(3):158-66. PubMed ID: 20679560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of funding source on effect size in randomized controlled trials: 2013-2015 - a cross-sectional survey and meta-analysis.
    Falk Delgado A; Falk Delgado A
    Trials; 2017 Mar; 18(1):125. PubMed ID: 28292317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of industry collaboration on randomised controlled trials in oncology.
    Linker A; Yang A; Roper N; Whitaker E; Korenstein D
    Eur J Cancer; 2017 Feb; 72():71-77. PubMed ID: 28027518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.
    Bhandari M; Busse JW; Jackowski D; Montori VM; Schünemann H; Sprague S; Mears D; Schemitsch EH; Heels-Ansdell D; Devereaux PJ
    CMAJ; 2004 Feb; 170(4):477-80. PubMed ID: 14970094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-declared stock ownership and association with positive trial outcome in randomized controlled trials with binary outcomes published in general medical journals: a cross-sectional study.
    Falk Delgado A; Falk Delgado A
    Trials; 2017 Jul; 18(1):354. PubMed ID: 28747226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is funding source related to study reporting quality in obesity or nutrition randomized control trials in top-tier medical journals?
    Kaiser KA; Cofield SS; Fontaine KR; Glasser SP; Thabane L; Chu R; Ambrale S; Dwary AD; Kumar A; Nayyar G; Affuso O; Beasley M; Allison DB
    Int J Obes (Lond); 2012 Jul; 36(7):977-81. PubMed ID: 22064159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials.
    Pang WK; Yeter KC; Torralba KD; Spencer HJ; Khan NA
    Int J Rheum Dis; 2015 Jul; 18(6):606-15. PubMed ID: 26012523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sponsors' participation in conduct and reporting of industry trials: a descriptive study.
    Lundh A; Krogsbøll LT; Gøtzsche PC
    Trials; 2012 Aug; 13():146. PubMed ID: 22920226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005.
    Ridker PM; Torres J
    JAMA; 2006 May; 295(19):2270-4. PubMed ID: 16705108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Are treatment effects or adverse effects of significance for the association between financing and conclusions in randomized trials?].
    Als-Nielsen BE; Chen W; Gluud CN; Gluud LL
    Ugeskr Laeger; 2004 Apr; 166(18):1676-8. PubMed ID: 15174406
    [No Abstract]   [Full Text] [Related]  

  • 19. Industry Collaboration and Primary Guest Authorship of High-Impact Randomized Clinical Trials: A Cross-Sectional Study.
    Roper N; Korenstein D
    J Gen Intern Med; 2015 Oct; 30(10):1421-5. PubMed ID: 25832619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of reporting randomised clinical trials in dental and medical research.
    Sjögren P; Halling A
    Br Dent J; 2002 Jan; 192(2):100-3. PubMed ID: 11838001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.